---
title: "FDA update: Paclitaxel-coated devices for PAD cleared of excess mortality risk, proven safe and effective"
date: "2023-08-29T08:44:21.000Z"
publishedDate: "29 août 2023"
summary: "This advertorial is sponsored by Boston Scientific. Data on hundreds of thousands of patients who have received lower limb endovascular treatment provide confidence in paclitaxel safety."
importance: ""
sourceUrl: "https://vascularnews.com/fda-update-paclitaxel-coated-devices-for-pad-cleared-of-excess-mortality-risk-proven-safe-and-effective/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2023-08-29-fda-update-paclitaxel-coated-devices-for-pad-cleared-of-excess-mortality-risk-proven-safe-and-effective"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/08/BSci-advertorial-image-web.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/fda-update-paclitaxel-coated-devices-for-pad-cleared-of-excess-mortality-risk-proven-safe-and-effective/"
---

![FDA update: Paclitaxel-coated devices for PAD cleared of excess mortality risk, proven safe and effective](https://vascularnews.com/wp-content/uploads/sites/7/2023/08/BSci-advertorial-image-web.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/fda-update-paclitaxel-coated-devices-for-pad-cleared-of-excess-mortality-risk-proven-safe-and-effective/*

## L’essentiel

This advertorial is sponsored by Boston Scientific. Data on hundreds of thousands of patients who have received lower limb endovascular treatment provide confidence in paclitaxel safety.

## Lien source

https://vascularnews.com/fda-update-paclitaxel-coated-devices-for-pad-cleared-of-excess-mortality-risk-proven-safe-and-effective/
